Sun Pharma announced the launch of Imatinib Mesylate Tablets (therapeutic equivalent to Gleevec® for indications approved by the FDA) to be used in the U.S. market as of February 1, 2016. Sun Pharma has launched an exclusive patient website www.imatinibrx.com providing detailed information about its Imatinib Mesylate, approved indications, side effects etc. Additionally, generic tadalafil the website features detailed FAQs on the tadalafil online product. Eligible patients can participate in Sun Pharma’s Imatinib Mesylate Savings Card program by registering online at www.imatinibrx.com or by requesting a savings card from their Oncologist. Sun Pharma will be supplying its Imatinib Mesylate Savings Cards to over 4,500 Oncologists.
A presentation was made by Dr. Margaret von Mehren, M.D., Director, Sarcoma Program, Martin Belinsky, Ph.D., Staff Scientist and Lori Rink, Ph.D., Principal Investigator, on current GIST research and progress being made at Fox Chase. Tania and Robert Stutman of GCRF presented a check for $100,000.
A presentation by Dr. Christopher Corless, MD, PhD
Professor of Pathology, Oregon Health & Science University
Chief Medical Officer, Knight Diagnostic Laboratories
PLEASE JOIN US
GIST EDUCATIONAL CONFERENCE AND LUNCHEON
Date: Tuesday, April 21, 2015
Time: 9:30 a.m. to 1:30 p.m., with an optional lab tour to follow
Location: OHSU Center for Health & Healing
3303 SW Bond Ave, Portland, OR 97239
The OHSU Knight Cancer Institute and the GIST Cancer Research Fund
cordially invite you to Oregon Health & Science University on
Tuesday, April 21, for a one-day GIST Educational Conference highlighting
advancements in Gastrointestinal Stromal Tumors (GIST) research.
Brian Druker, M.D.
Christopher Corless, M.D., Ph.D.
Michael Heinrich, M.D.
Caroline Macuiba, LCSW, OSW-C
For questions and to RSVP: 503 552-0681 or email@example.com.
We will mail a detailed agenda and parking information.
You are cordially invited toA PRESENTATION TO THE GIST CANCER RESEARCH FUND featuring updates on the most recent research and achievements in clinical treatments at Memorial Sloan Kettering Cancer Center Wednesday, April 1, 2015 3:00 p.m. Rockefeller Research Laboratories, Room 104 Memorial Sloan Kettering Cancer Center 430 East 67th Street New York City
Please reserve your place by Monday, March 30 Ms. Audrey Williams firstname.lastname@example.org or 646.227.3531
S P E A K E R S: Benedikt Bosbach, PhD – “Mouse Models Unraveling Therapeutic Avenues in GIST” Cristina R. Antonescu, MD – “Integrating Genomic Data in Wild Type and Pediatric GIST” Ping Chi, MD, PhD – “Targeting ETV1 in GIST” Ronald P. DeMatteo, MD, FACS – “A New Therapeutic Approach in GIST”
Presentations will be followed by a tour of Dr. DeMatteo’s lab in the Zuckerman Research Center 417 East 68th Street